8
Oct
2024

OnDosis AB

Exhibitor at CPHI Milan 2024 stand 6SU79, Excipients
About Us

OnDosis is an AstraZeneca spin out founded in 2017 and headquartered in Sweden. The company is developing a first in category technical platform for precision and flexible dosing of oral solid medicines, formulated as multi particulates such as granules, pellets, powders and mini tablets. The core of the technology, a connected handheld device, is used in an home environment by patients or caregivers to deliver individualized dosing and manage dose adjustments.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • SE
  • 2023
    On CPHI since
  • 25 - 49
    Employees
Company types
Drug delivery device Supplier/Manufacturer
Primary activities
Medical Devices
Packaging & drug delivery
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 6SU79, Excipients

Products Featured at CPHI Milan 2024

  • OnDosis Dosage Manager

    Product OnDosis Dosage Manager

    The Dosage Manager is a first in class technology for oral solids formulations such as pellets, granules, powder and minitablet formulations. The technology provides a new packaging and drug delivery option for treatments where dosing is complex, requires adjustments or more precision than current opti...